POS1121 THE USE OF THE CD3/CD19 T CELL ENGAGER BLINATUMOMAB IN SEVERE SYSTEMIC SCLEROSIS: A CASE SERIESM. Scherlinger, J. Sibilia, A. Moltó et al.|Annals of the Rheumatic Diseases|2025Cited by 3